The market has been down on China Biologic Products Holdings Inc (CBPO) stock recently. CBPO gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With CBPO Stock Today?
China Biologic Products Holdings Inc (CBPO) stock is trading at $108.28 as of 1:20 PM on Tuesday, Sep 15, a rise of $1.89, or 1.78% from the previous closing price of $106.39. The stock has traded between $106.89 and $108.70 so far today. Volume today is light. So far 61,251 shares have traded compared to average volume of 102,376 shares.
To see InvestorsObserver's Sentiment Score for China Biologic Products Holdings Inc click here.
More About China Biologic Products Holdings Inc
China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.
Click Here to get the full Stock Score Report on China Biologic Products Holdings Inc (CBPO) Stock.
